Biotech

All Articles

Vir gains 3 T-cell engagers from Sanofi, gives up 25% of team

.Vir Biotechnology's second-quarter revenues report wasn't except large updates. The provider welcom...

Galapagos stops briefly CAR-T tissue treatment trial over Parkinsonism situation

.Galapagos has stopped enrollment in a trial of a BCMA-directed CAR-T cell treatment, pushing the br...

James Wilson leaving Penn to launch two brand-new biotechs

.After more than thirty years, genetics treatment pioneer James Wilson M.D., Ph.D., is leaving behin...

3 biotechs make an effort to trump the summer season heat through dropping staff

.As biotechs seek to switch a new web page in August, at least 3 companies have shed workers in effo...

venBio lifts $528M for 5th lifestyle sciences VC fund

.Pro venture capital firm venBio has raised yet another half a billion bucks to acquire biotechs wor...

Otsuka pays $800M for Jnana as well as its clinical-stage PKU drug

.Otsuka Pharmaceutical has actually picked up Boston-based Jnana Therapeutics for $800 million so th...

FibroGen gives up 75% people workers as possession flunks 2 even more tests

.FibroGen is significantly restructuring its company, laying off 75% of its own USA workers as well ...

Tracon unwind weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has decided to unwind procedures weeks after an injectable invulnerable gate...

Ideaya bags choice on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M reduction on fallen short epilepsy medicine, touts FDA run

.Our experts presently recognize that Takeda is actually expecting to discover a course to the FDA f...